Catalog Numbers: HEP-003-OTC-a, HEP-003-ASS1-a
pixHep UCD (Urea Cycle Disorder) Models (ASS1, and OTC)
pixHep iPSC-derived hepatocyte models capturing key enzymatic defects in the urea cycle (ASS1 and OTC).
- CRISPR-engineered, cryopreserved vials (1 × 10⁶ viable cells per vial) available as ASS1 (G390R) or OTC (D175V) mutant lines
- Reproduce reduced ammonia detoxification, impaired enzyme expression, and decreased urea output
- Ideal for evaluating small molecules, gene therapies, and enzyme restoration strategies targeting UCD
Place your Order
Our UCD portfolio includes OTC D175V-mutant and ASS1-knockout hepatocytes, each displaying impaired urea cycle function and measurable metabolic imbalance.
These models enable direct testing of gene therapies, enzyme replacement, and metabolic modulators in a fully human system.
Reduced enzyme activity confirmed via metabolic assays.
Elevated ammonia and altered metabolite profiles.
Isogenic controls for genotype–phenotype matching.
CRISPR customisation for additional UCD variants.
Technical Data & Functional Validation
Functional Urea Cycle Pathway

Successful OTCD iPSC Differentiation

Decreased OTC Expression

Decreased ASS1 Expression

Streamline Your Research
Ready to Turn Your Cells Into Data?
Our pixCell portfolio seamlessly integrates into custom data generation projects—from functional assays (pixCellServices) to phenomic analysis (pixCellPaint)—delivering ready-to-use data at your fingertips.









